In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Transcatheter mitral valve repair in functional mitral regurgitation : time for evidence!
Session

Congress : ESC Congress 2018

Topic : Valvular Heart Disease

  • Session type : Satellite Symposium
  • Date : 28 August 2018
  • Time : 13:00 - 14:00
  • Sponsored by Abbott

6 presentations in this session

Introduction - Transcatheter mitral valve repair in functional mitral regurgitation : time for evidence!

Congress : ESC Congress 2018

  • Session : Transcatheter mitral valve repair in functional mitral regurgitation : time for evidence!
  • Sponsored by Abbott

Guidelines ESC/EACTS/HF for functional mitral regurgitation treatment.

Congress : ESC Congress 2018

  • Session : Transcatheter mitral valve repair in functional mitral regurgitation : time for evidence!
  • Speaker : V Falk (Berlin,DE)
  • Sponsored by Abbott

Functionnal mitral regurgitation: all you need to know.

Congress : ESC Congress 2018

  • Session : Transcatheter mitral valve repair in functional mitral regurgitation : time for evidence!
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by Abbott

Value of MitraClip in reducing burden of FMR.

Congress : ESC Congress 2018

  • Session : Transcatheter mitral valve repair in functional mitral regurgitation : time for evidence!
  • Speaker : S Windecker (Bern,CH)
  • Sponsored by Abbott

How MitraFR & COAPT trials would change the way to treat my patient?

Congress : ESC Congress 2018

  • Session : Transcatheter mitral valve repair in functional mitral regurgitation : time for evidence!
  • Speaker : W Abraham (Columbus,US), JF Obadia (Lyon-Bron Cedex,FR)
  • Sponsored by Abbott

Conclusion - Transcatheter mitral valve repair in functional mitral regurgitation : time for evidence!

Congress : ESC Congress 2018

  • Session : Transcatheter mitral valve repair in functional mitral regurgitation : time for evidence!
  • Sponsored by Abbott

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are